INMUNE BIO INC (INMB)
US45782T1051 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 35.85M | 52.15M | 74.81M | 21.97M | 7.00M | |||
| Receivables | 2.44M | 8.46M | 5.50M | 1.80M | 650.00K | |||
| Other Current Assets | 1.65M | 4.06M | 2.29M | 220.00K | 120.00K | |||
| Total Current Assets | 39.94M | 64.68M | 82.61M | 23.99M | 7.76M | |||
| Non-Current Assets | ||||||||
| PPE Net | 414.00K | 510.00K | 730.00K | 160.00K | 190.00K | |||
| Intangibles | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M | |||
| Other Non-Current Assets | 131.00K | 100.00K | 100.00K | N/A | N/A | |||
| Total Non-Current Assets | 17.06M | 17.12M | 17.34M | 16.67M | 16.71M | |||
| TOTAL ASSETS | 57.00M | 81.80M | 99.95M | 40.66M | 24.47M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 9.92M | 5.00M | N/A | N/A | N/A | |||
| Accrued Expenses | 119.00K | 90.00K | 70.00K | 30.00K | 10.00K | |||
| Accounts Payable | 7.94M | 5.22M | 3.81M | 1.55M | 690.00K | |||
| Other Current Liabilities | 489.00K | 620.00K | 470.00K | 190.00K | N/A | |||
| Total Current Liabilities | 18.46M | 10.92M | 4.36M | 1.78M | 700.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 9.70M | 14.46M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 397.00K | 1.08M | 900.00K | 130.00K | 160.00K | |||
| Total Non-Current Liabilities | 397.00K | 10.77M | 15.36M | 120.00K | 160.00K | |||
| TOTAL LIABILITIES | 18.86M | 21.69M | 19.72M | 1.90M | 860.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -121.02M | -91.01M | -63.72M | -33.38M | -21.28M | |||
| Additional Paid In Capital | 159.14M | 151.80M | 143.92M | 72.10M | 44.83M | |||
| Common Shares | 817.00K | 20.00K | 20.00K | 10.00K | 60.00K | |||
| Other Shareholders' Equity | -799.00K | -700.00K | 0.00 | 10.00K | -10.00K | |||
| Shares Outstanding | 17.95M | 17.95M | 17.84M | 13.48M | 10.77M | |||
| Tangible Book Value per Share | 1.20 | 2.43 | 3.57 | 1.65 | 0.66 | |||
| Total Shareholders' Equity | 38.14M | 60.10M | 80.23M | 38.75M | 23.61M | |||
| TOTAL LIABILITIES AND EQUITY | 57.00M | 81.80M | 99.95M | 40.66M | 24.47M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.16 | 0.18 | N/A | N/A | |||
| Current Ratio | 2.16 | 5.92 | 18.95 | 13.48 | 11.09 | |||
| Return On Assets (ROA) | -52.64% | -33.37% | -30.36% | -29.76% | -31.39% | |||
| Return On Equity (ROE) | -78.68% | -45.42% | -37.82% | -31.23% | -32.53% | |||
All data in USD